JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹329 Cr | ₹278 Cr | ₹225 Cr | ₹203 Cr | ₹171 Cr |
What is the latest Total Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹329 Cr |
| Mar2025 | ₹278 Cr |
| Mar2024 | ₹225 Cr |
| Mar2023 | ₹203 Cr |
| Mar2022 | ₹171 Cr |
How is Total Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹329 Cr | 18.34 | |
| Mar2025 | ₹278 Cr | 23.87 | |
| Mar2024 | ₹225 Cr | 10.90 | |
| Mar2023 | ₹203 Cr | 18.18 | |
| Mar2022 | ₹171 Cr | - | |
Compare Total Liabilities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,517.0 Cr | 9% | -5.5% | 0.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | 9% |
-5.5% |
0.5% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses